Works matching IS 1007385X AND DT 2022 AND VI 29 AND IP 12

Results: 10

甲基转移酶样因子3通过调控GLUT4-mTORCl轴影响食管鳞状细胞癌细胞的糖酵解及增殖

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1076, doi. 10.3872/j.issn.1007-385x.2022.12.003

By:

周锡小;
钟晓武;
高川力;
李青容;
程吉兵;
马强;
郭晓兰

Publication type:

Article

以NKG2A为靶点的肿瘤免疫治疗:现状、问题与对策.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1067, doi. 10.3872/j.issn.1007-385x.2022.12.002

By:

韩鹏虎;
张彩

Publication type:

Article

肿瘤免疫微环境中的NK细胞及免疫治疗.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1057, doi. 10.3872/j.issn.1007-385x.2022.12.001

By:

王旭奔;
魏海明;
郑小虎

Publication type:

Article

基于miRNA-mRNA网络筛查并验证胃癌诊断和预后评估相关的标志物及其潜在分子机制

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1094, doi. 10.3872/j.issn.1007-385x.2022.12.005

By:

李昶蓥;
郭志云

Publication type:

Article

潜伏期相关核抗原在卡波西肉瘤发生及靶向治疗中的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1136, doi. 10.3872/j.issn.1007-385x.2022.12.011

By:

张盼盼;
王鹏;
康晓静

Publication type:

Article

circFBXL5通过靶向miR-515-5p影响膀胱癌T24细胞的恶性生物学行为及其分子机制.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1101, doi. 10.3872/j.issn.1007-385x.2022.12.006

By:

邓海波;
于剑刚;
陈一帆;
朱枕砚;
陈武

Publication type:

Article

PD-L1:CD80顺式作用对肿瘤免疫治疗的启示.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1130, doi. 10.3872/j.issn.1007-385x.2022.12.010

By:

魏枫;
任秀宝

Publication type:

Article

脾多肽注射液联合FOLFOX4或XELOX治疗III/W期结肠癌术后患者的疗效及不良反应的比较

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1125, doi. 10.3872/j.issn.1007-385x.2022.12.009

By:

戴玉容;
郭朝晖

Publication type:

Article

基于生物信息学数据分析ELTD1在肾透明细胞癌组织中的表达、甲基化水平及其临床意义

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1115, doi. 10.3872/j.issn.1007-385x.2022.12.008

By:

黄逸婷;
王珂;
方晨

Publication type:

Article

肿瘤相关巨噬细胞及CD8+/CD68+细胞比值是影响肺腺癌患者预后的独立危险因素.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 12, p. 1108, doi. 10.3872/j.issn.l007-385x.2022.12.007

By:

张洪玉;
何娴;
沈琼;
刘颖婷;
陈陆俊;
郑晓;
王智刚

Publication type:

Article